login
  Password reminder
Spinal News
Contact the editor Visit Spinal News Twitter feed Visit Spinal News Facebook page
 

Spinal Modulation Neurostimulator system receives CE mark for the management of chronic intractable pain


Monday, 12 Dec 2011 11:03
Spinal Modulation Neurostimulator system
Spinal Modulation Neurostimulator system


The Spinal Modulation Neurostimulator system (Spinal Modulation) has received CE mark for the management of chronic intractable pain. This system utilises low-level electrical signals to modulate neural structures of primary sensory neurons located within the dorsal root ganglion. These cell bodies have been implicated in the development and maintenance of chronic pain conditions.


Liong Liem and Paul Verrills presented the initial results of the world’s first multicentre prospective clinical trial to assess the management of chronic pain through stimulation of the dorsal root at the 15th Annual North American Neuromodulation Society (NANS) conference in Las Vegas, USA.

“The Spinal Modulation system has provided substantial benefit to a number of my patients with chronic intractable pain that have not had adequate pain relief with other spinal cord stimulation systems. For example, patients with chronic intractable pain in the lower extremities are typically very difficult to treat with existing spinal cord stimulation systems. With the Spinal Modulation system, I have seen very encouraging results in patients with this type of pain condition,” said Liem, director of the Pain Management Practice at Sint Antonius Hospital in The Netherlands.

Neurostimulation therapy is a proven method of managing chronic pain. It uses an implantable medical device to deliver mild electrical pulses to neural tissue to mask or interrupt pain signals as they travel to the brain. With dorsal column spinal cord stimulation, small wires are placed along the midline of the epidural space. With the Spinal Modulation therapy, physicians place a specialised neuromodulation system in the epidural space to target the dorsal root ganglion, which allows the signals to be masked or interrupted even before they enter the spinal cord.

“Spinal Modulation has taken a deliberate and scientific approach to developing this therapy. My practice has partnered with Spinal Modulation to help demonstrate the clinical utility of neuromodulation of the dorsal root ganglion in patients with chronic, intractable pain. I am very enthusiastic that they have developed practical and clinically useful tools for long-term stimulation of the dorsal root ganglion and I look forward to its commercial availability in my practice in Australia,” said Marc Russo, Director of the Hunter Pain Clinic in Newcastle, Australia.

The company has begun international commercialisation and plans to continue clinical research in order to advance dorsal root ganglion stimulation and provide pain relief for more patients.

The Spinal Modulation Neurostimulator system is not approved for use or sale in the United States.




Add New Comment

Most popular


Trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment
Wednesday, 23 Jul 2014
The study followed patients at five leading academic centres and found a significant decrease (p <0.01) in pain scores after targeted radiofrequency ablation (t-RFA) with the Star (DFINE) tumour ... Trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment

Minimus Spine secures the CE mark for its TrioJection system
Monday, 04 Aug 2014
Minimus Spine has announced that it has successfully secured ISO 13485 certification of its quality management system and also the CE mark for its TrioJection system for delivering ozone to a ... Minimus Spine secures the CE mark for its TrioJection system

Cost of implants is a barrier to spinal deformity surgery in low income countries
Wednesday, 30 Jul 2014
Despite the cost of pedicle screws being lower in low income countries than in high income countries, the cost of implants is a principal barrier to children having corrective surgery for spinal ... Cost of implants is a barrier to spinal deformity surgery in low income countries

Features


3D-printed implants are a “real step forward” in spinal surgery
Friday, 12 Sep 2014
Vincent Fiere performed the world’s first spinal surgery (anterior lumbar interbody fusion) with a 3D printed customised cage (UNiD, Medicrea). He speaks to Spinal News International about the ... 3D-printed implants are a “real step forward” in spinal surgery

Managing back pain in children
Friday, 29 Aug 2014
Omar Gabbar reviews the prevalence and management of back pain in children and adolescents, including the importance of excluding serious pathologies. Managing back pain in children

Profiles


Lori Karol
Wednesday, 13 Aug 2014
Lori Karol, Texas Scottish Rite Hospital, Dallas, USA, talks to Spinal News International about the ... Lori Karol

Luiz Pimenta
Thursday, 12 Jun 2014
Luiz Pimenta, immediate past president of the International Society for the Advancement of Spinal S... Luiz Pimenta

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions